logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
C

Cyrille Touzeau

Nantes University Hospital
H指数:49
被引数:1.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

B-Cell Maturation Antigen T-Cell Engager Therapy in a Patient With Refractory Plasma Cell Clonal Cryoglobulinemia Unmasked by RNA-Based Immunoglobulin Sequencing

B细胞成熟抗原T细胞衔接疗法在一名经RNA基免疫球蛋白测序确诊的难治性浆细胞克隆性冷球蛋白血症患者中的应用

American Journal of Kidney Diseases
IF8.2
2026-11-030
PRE
Bénédicte Piron; Jérôme Han Yee Yu; Hélène Caillon; Virginie Pascal; Benoit Tessoulin; Cyrille Touzeau; Yannick Le Bris; Karine Renaudin; Nicolas Blin; Simon Ville
MK-4002, a B-cell maturation antigen-targeting T-cell engager, in relapsed or refractory multiple myeloma: a first-in-human, open-label, phase 1 study

MK-4002，一种靶向B细胞成熟抗原的T细胞接合剂，在复发或难治性多发性骨髓瘤中的应用：一项首次人体、开放标签的1期研究

Lancet Haematology
IF17.7
2026-10-060
PRE
Sumit Madan; Caitlin Costello; Brea Lipe; Andrew J Cowan; Eva Medvedova; Jens Hillengass; P Leif Bergsagel; Xavier Leleu; Cyrille Touzeau; Daniel Morillo; Albert Oriol; Raya Mawad; Henning Schade; Yifah Yaron; Patrick P Ng; Banmeet Anand; Razia Akhtar; Al-Ola Abdallah
MAIA frailty subgroup analysis: long-term follow-up with daratumumab plus lenalidomide/dexamethasone in transplant-ineligible newly diagnosed myeloma

MAIA虚弱亚组分析：在移植不适用的 newly diagnosed myeloma 患者中使用达拉珠单抗联合来那度胺/地塞米松的长-term随访

Leukemia
IF13.4
2026-10-060
OAAI
Thierry Facon; Gordon Cook; Saad Z. Usmani; Cyrille Hulin; Shaji Kumar; Cyrille Touzeau; Nizar J. Bahlis; Supratik Basu; Hartmut Goldschmidt; Hang Quach; Mohamad Mohty; Christopher P. Venner; Katja Weisel; Noopur Raje; Salomon Manier; Mai Ngo; Marjohn Armoon; Kasey Bolyard; Fredrik Borgsten; Robin Carson; Sonja Zweegman
Longitudinal assessments of MRD in high-risk newly diagnosed transplant-ineligible multiple myeloma in the BENEFIT study (IFM2020-05)

BENEFIT研究（IFM2020-05）中高危初诊非移植候选多发性骨髓瘤的MRD纵向评估

HemaSphere
IF14.6
2026-10-050
OAAI
Jill Corre; Jerome Lambert; Arthur Bobin; Salomon Manier; Aurore Perrot; Lionel Karlin; Murielle Roussel; Noemie Bigot; Omar Benbrahim; Olivier Allangba; Philippe Rey; Véronique Dorvaux; Marguerite Vignon; Virginie Roland; Réda Garidi; Jean-Noel Bastie; Marie-Lorraine Chretien; Sophie Godet; Lydia Montes; Brieuc Cherel; Anne Vekhoff; Thomas Chalopin; Borhane Slama; Kamel Laribi; Claire Dingremont; Christophe Roul; Valentine Richez-Olivier; Clara Mariette; Sophie Rigaudeau; Claire Calmettes; Mamoun Dib; Mourad Tiab; Laure Vincent; Jacques Delaunay; Sabrina Maheo; Anais Schavgoulidze; Laurent Frenzel; Pascal Godmer; Ronan Le Calloch; Emilie Chalayer; Helene Gardeney; Margaret Macro; Bruno Royer; Stephanie Harel; Olivier Decaux; Bertrand Arnulf; Karim Belhadj; Aurelie Gontier; Cyrille Touzeau; Mohamad Mohty; Philippe Moreau; Thierry Facon; Cyrille Hulin; Xavier Leleu
Clinical outcomes of newly diagnosed myeloma patients with SLIM criteria : a subgroup analysis of the CASSIOPEIA study

新诊断多发性骨髓瘤患者SLIM标准下的临床结局：CASSIOPEIA研究中的亚组分析

Leukemia
IF13.4
2026-08-130
PRE
Cyrille Touzeau; Aurore Perrot; Cyrille Hulin; Mammoun Dib; Gedeon Agbetsivi; Laure Vincent; Thierry Facon; Xavier Leleu; Niels W.C.J. van de Donk; Annemiek Broijl; Sonja Zweegman; Michel Delforge; Jill Corre; Pieter Sonneveld; Ariane Boumendil; Philippe Moreau
Response profile and long-term outcomes in Cyclin D1-overexpressing multiple myeloma: insights from the CASSIOPEIA trial

Cyclin D1过表达多发性骨髓瘤的反应特征和长期结局：来自CASSIOPEIA试验的见解

Blood Cancer Journal
IF11.6
2026-07-030
OAAI
Aurore Perrot; Cyrille Touzeau; Stéphane Minvielle; Cyrille Hulin; Denis Caillot; Salomon Manier; Xavier Leleu; Cécile Sonntag; Karim Belhadj; Bertrand Arnulf; Thomas Chalopin; Jean-Richard Eveillard; Martine Escoffre-Barbe; Lionel Karlin; Laure Vincent; Margaret Macro; Hervé Avet-Loiseau; Soraya Wuilleme; Ariane Boumendil; Jill Corre; Philippe Moreau
Expression profile of CASSIOPEIA patients refines prognostic value of MRD negativity in multiple myeloma

CASSIOPEIA患者表达谱优化了多发性骨髓瘤中MRD阴性的预后价值

Blood Cancer Journal
IF11.6
2026-07-020
OAAI
Florence Magrangeas; Catherine Guérin-Charbonnel; Victor Bessonneau-Gaborit; Marie Denoulet; Nils Giordano; Aurore Perrot; Cyrille Touzeau; Mark van Duin; Magali Devic; Elise Douillard; Eric Letouzé; Pieter Sonneveld; Jill Corre; Stéphane Minvielle; Philippe Moreau
Cilta-cel in lenalidomide-refractory multiple myeloma (CARTITUDE-4): an updated analysis including overall survival from an open-label, multicentre, randomised, phase 3 trial

Cilta-cel 在来那度胺难治性多发性骨髓瘤中的疗效（CARTITUDE-4）：一项开放标签、多中心、随机、III期试验的更新分析，包括总生存期数据

The Lancet Oncology
IF0
2026-01-070
OAAI
Hermann Einsele; Jesús San-Miguel; Binod Dhakal; Cyrille Touzeau; Xavier Leleu; Niels WCJ van de Donk; Surbhi Sidana; Albert Oriol; Yael C Cohen; Simon J Harrison; María-Victoria Mateos; Joaquín Martínez-López; Paolo Corradini; Lionel Karlin; Diana Chen; Quanlin Li; Tzu-min Yeh; Katherine Li; Vicki Plaks; Ana Slaughter
35 years of academic trials focusing on high-dose therapy and autologous stem cell transplantation: the Intergroupe Francophone du Myélome (IFM) experience

35年专注于高剂量疗法和自体干细胞移植的学术研究：法国骨髓瘤研究组(IFM)的经验

Blood Cancer Journal
IF11.6
2025-10-240
OA
Philippe Moreau; Cyrille Hulin; Alexis Talbot; Hélène Demarquette; Léo Caillot; Thomas Chalopin; Arthur Bobin; Salomon Manier; Xavier Leleu; Lionel Karlin; Denis Caillot; Cécile Sonntag; Pierre Feugier; Murielle Roussel; Romain Gounot; Margaret Macro; Mohamad Mohty; Laurent Garderet; Mourab Tiab; Frédérique Orsini-Piocelle; Laure Vincent; Nathalie Meuleman; Jean Fontan; Lidia Montes; Marie-Christiane Vekemans; Martine Escoffre-Barbe; Jean-Richard Eveillard; Jean-Marc Schiano de Colella; Jérôme Lambert; Jean-Yves Mary; Jean-Paul Fermand; Bertrand Arnulf; Jill Corre; Hervé Avet-Loiseau; Thierry Facon; Jean-Luc Harousseau; Cyrille Touzeau; Aurore Perrot
European Myeloma Network Group Consensus Statement on the use of next-generation sequencing for prognostic stratification of newly diagnosed multiple myeloma

欧洲骨髓瘤网络工作组关于下一代测序在 newly diagnosed multiple myeloma 预后分层中应用的共识声明

HemaSphere
IF14.6
2025-10-130
OAAI
Niccolò Bolli; Mattia D'Agostino; Tina Bagratuni; Mario Boccadoro; Michele Cavo; Christoph Driessen; Hermann Einsele; Monika Engelhardt; Francesca Gay; Norma C. Gutiérrez; Roman Hájek; Toril Holien; Cristina João; Martin Kaiser; K. Martin Kortüm; Lisa Leypoldt; Philippe Moreau; Pellegrino Musto; Enrique M. Ocio; Marc S. Raab; Leo Rasche; Fredrik Schjesvold; Tereza Sevcikova; Evangelos Terpos; Cyrille Touzeau; Niels W. C. J. Van de Donk; Mark van Duin; Katja Weisel; Elena Zamagni; Tom Cupedo; Pieter Sonneveld; Carolina Terragna
Safety and efficacy of a dexamethasone-sparing regimen with daratumumab and lenalidomide in patients with frailty and newly diagnosed multiple myeloma (IFM2017-03): a phase 3, open-label, multicentre, randomised, controlled trial

脆弱及新诊断多发性骨髓瘤患者中地塞米松减量方案联合达拉珠单抗和来那度胺的安全性与有效性（IFM2017-03）：一项III期、开放标签、多中心、随机对照试验

The Lancet Oncology
IF0
2025-09-290
OAAI
Salomon Manier; Jérôme Lambert; Cyrille Hulin; Margaret Macro; Kamel Laribi; Carla Araujo; Gian Matteo Pica; Cyrille Touzeau; Pascal Godmer; Borhane Slama; Lionel Karlin; Frédéric Orsini Piocelle; Mamoun Dib; Laurence Sanhes; Pierre Morel; Abderazzak El Yamani; Mourad Tiab; Reza Tabrizi; Valentine Richez; Laurent Garderet; Bruno Royer; Benoit Bareau; Clara Mariette; Emmanuel Fleck; Daniela Robu; Claire Calmettes; Sophie Rigaudeau; Hélène Demarquette; Laurent Frenzel; Olivier Decaux; Mohamad Mohty; Bertrand Arnulf; Noémie Bigot; Aurore Perrot; Jill Corre; Jean-Yves Mary; Hervé Avet-Loiseau; Philippe Moreau; Xavier Leleu; Thierry Facon
Prognostic value of premaintenance FDG PET/CT response in patients with newly diagnosed myeloma from the CASSIOPEIA trial

CASSIOPEIA试验中，新诊断多发性骨髓瘤患者维持治疗前的FDG PET/CT反应的预后价值

Blood
IF23.1
2025-09-260
PRE
Françoise Kraeber-Bodéré; Bastien Jamet; Sonja Zweegman; Aurore Perrot; Cyrille Hulin; Denis Caillot; Thierry Facon; Xavier Leleu; Karim Belhadj; Emmanuel Itti; Lionel Karlin; Clément Bailly; Mark-David Levin; Monique C. Minnema; Caroline Bodet-Milin; Bart de Keizer; Jill Corre; Pieter Sonneveld; Philippe Moreau; Thomas Carlier; Cyrille Touzeau
Poor Outcomes with BCMA-targeting bispecific antibodies following early relapse from ide-cel: a real-world French study

从ide-cel早期复发后使用靶向BCMA的双特异性抗体治疗效果不佳：一项法国真实世界研究

Blood Advances
IF7.1
2025-09-200
OAAI
Sarah Cayla; Lionel Karlin; Jérôme Lambert; Anne Lazareth; Alexis Talbot; Mohamad Mohty; Florent Malard; Marie-Odile Petillon; Salomon Manier; Ibrahim Yakoub-Agha; Denis Caillot; Ingrid Lafon; Xavier Leleu; Niels Moya; Bruno Royer; Jean-Marc Schiano De Colella; Gabriel Brisou; Cyrille Touzeau; Aurore Perrot; Pierre Bories; Laure Vincent; Hanane Guedon; Olivier Decaux; Benoît Ferment; Roch Houot; Steven Le Gouill; Noémie Bigot; Thierry Facon; Jill Corre; Hervé Avet-Loiseau; Philippe Moreau; Bertrand Arnulf
Comparative Effectiveness of Ciltacabtagene Autoleucel in CARTITUDE-4 Versus Real-World Physician’s Choice of Therapy from the Flatiron Registry in Lenalidomide-Refractory Multiple Myeloma

Ciltacabtagene autoleucel在CARTITUDE-4研究中的比较有效性，与来自Flatiron登记研究中来那度胺难治性多发性骨髓瘤的真实世界医生选择疗法进行比较

Advances in Therapy
IF4
2025-08-060
OAAI
Cyrille Touzeau; Brea Lipe; Abdullah M. Khan; Binod Dhakal; Sandhya Nair; Jianming He; João Mendes; Seina Lee; Carolina Lonardi; Ana Slaughter; Nikoletta Lendvai; Jordan M. Schecter; Diana Chen; Man Zhao; Tzu-min Yeh; Xavier Leleu; Noemí Puig; Dominik Dytfeld; Elena Zamagni; Katja Weisel; Lionel Karlin; Michel Delforge; Paolo Corradini; Roberto Mina; Wilfried Roeloffzen; Surbhi Sidana
Safety of venetoclax in real-world experience: data from the French national database of pharmacovigilance through all indications in hematological malignancies over 5 years

venetoclax在真实世界经验中的安全性：来自法国全国药物警戒数据库的数据，涵盖5年内血液系统恶性肿瘤的所有适应症。

Therapeutic Advances in Hematology
IF3.1
2025-07-290
OA
Alexis Talbot; Pierre-Edouard Debureaux; Agnès Lillo-Le Louet; Yasmine Derri; Marine Aroux-Pavard; Hélène Jantzem; David M. Smadja; Cyrille Touzeau; Christine Le Beller; Nicolas Gendron

研究方向

暂未获取到该数据
P
Philippe Moreau
H 指数:159论文数:2,293被引数:10.8万
A
Aurore Perrot
H 指数:43论文数:452被引数:1.1万
S
Steven Le Gouill
H 指数:69论文数:705被引数:1.8万
X
Xavier Leleu
H 指数:93论文数:1,209被引数:4.2万
T
Thomas Gastinne
H 指数:41论文数:327被引数:7,643
B
Benoît Tessoulin
H 指数:30论文数:231被引数:3,182
J
Jill Corre
H 指数:43论文数:572被引数:7,832
T
Thierry Façon
H 指数:113论文数:958被引数:6.1万
B
Beatrice Mahé
H 指数:34论文数:236被引数:4,808
C
Cyrille Hulin
H 指数:45论文数:317被引数:1.3万